News Image

Collegium Completes Acquisition of Ironshore Therapeutics

Provided By GlobeNewswire

Last update: Sep 4, 2024

Adds Commercial Product Jornay PM®, Establishing Collegium’s Presence in Neurology (ADHD) –

– Collegium Updates 2024 Financial Guidance to Reflect Expected Immediate Accretion from the Ironshore Acquisition –

Read more at globenewswire.com

COLLEGIUM PHARMACEUTICAL INC

NASDAQ:COLL (4/25/2025, 8:00:00 PM)

After market: 26.79 0 (0%)

26.79

+0.01 (+0.04%)



Find more stocks in the Stock Screener

Follow ChartMill for more